A new European health mapping report reveals that 80 percent of women living with a partner who has obesity or overweight feel concerned about his long-term health, while half of those partners take no action regarding their weight. Released by digital healthcare provider Yazen, the data highlights a significant gap between severe medical risks and men’s willingness to seek professional medical care.
European Health Mapping Exposes Male Healthcare Hesitation
The European mapping project, published by Yazen, surveyed 1,255 female patients across Sweden, Norway, Denmark, the Netherlands, and Germany. Out of those respondents, 35 percent—representing 436 women—reported that their male partner lives with overweight or obesity. Approximately 80 percent of these women expressed moderate to severe worry about long-term health consequences for their partners, such as cardiovascular disease and type 2 diabetes.
Obesity is a chronic and progressive disease that significantly increases the risk of premature death, heart disease, and type 2 diabetes. In Sweden alone, the condition costs society roughly 125 billion kronor annually. Despite these clear medical risks, men remain heavily underrepresented in obesity care and routinely delay seeking professional help.
Barriers to Treatment and Biological Realities
According to the survey responses from female partners, several primary obstacles prevent men from seeking medical intervention. A lack of insight regarding weight as a health problem accounts for 29 percent of barriers, followed by economic concerns at 20.4 percent, a general reluctance to visit doctors at 20.2 percent, and the perception that weight issues represent a personal failure at 19 percent.
“We see a clear pattern where many women worry about their partner’s health, while men often delay seeking help,” says Elin Skoglund, a physician and clinical manager at Yazen. “Many believe incorrectly that it is a personal failure that they should solve themselves. But obesity is a biologically driven disease where the brain’s appetite regulation is altered. It needs to be met with professional medical care, not with shame and moralizing.”
Digital Care Models and Treatment Outcomes
Traditional public primary care systems remain strained and often lack the resources to provide the continuous oversight that chronic obesity requires. Digital healthcare platforms aim to reduce these entry barriers by offering structured, long-term support for lasting health improvements.
“The treatment of obesity must be multidisciplinary,” Skoglund explains. “Our model combines modern medications with a complete care team consisting of a doctor, dietitian, psychologist, and physiotherapist. By offering care digitally, we can lower the threshold to evidence-based help and offer continuous support over time.”
Patient data from Yazen indicates that integrated digital treatment models achieve high retention rates, with 69 percent of patients remaining in treatment after 12 months. Treatment correlates with a reduction in sick leave, as 24 percent of patients report an average decrease of 5.2 sick days per year and individual.
Survey Methodology and Background
The mapping initiative gathered data exclusively from female Yazen patients in five European countries. The findings reflect the perceptions of female partners regarding the health behaviors and attitudes of the men in their lives.
Yazen operates as a digital healthcare provider specializing in the management of chronic obesity. The organization currently functions across eight countries, including Sweden, Norway, Denmark, the Netherlands, the United Kingdom, Germany, Switzerland, and Spain. The clinical workforce comprises 290 employees, including 210 clinical staff members and 115 licensed physicians. Current treatment cohorts include more than 50,000 active patients, while over 70,000 individuals have collectively lost more than 880 tons through the program.
Related reading